Treatment with dopamine-receptor agonists is associated with impulse control disorders, including pathological gambling, binge eating, and hypersexuality. Patients and their carers should be informed about the risk of impulse control disorders.

Pipexus 0.26mg modified-release tablets Ethypharm UK Ltd Show Cautionary and advisory labels. Label . 10 Warning: Read the additional information given with this medicine. Rhybudd: Darllenwch y wybodaeth ychwanegol gyda'r feddyginiaeth hon. Label . 25 Swallow this medicine whole. Do not chew or crush. Llyncwch yn gyfan. Peidiwch â chnoi neu ...

Pramipexole causes somnolence and episodes of sudden sleep onset in some people, and, uncommonly, without awareness or warning. People should exercise caution while driving or operating machines, and must not drive or operate machinery if they experience episodes of sudden sleep onset.

Pipexus is used to treat the symptoms of primary Parkinson’s disease in adults. It can be used alone or in combination with levodopa (another medicine for Parkinson’s disease). 2. What you need to know before you take Pipexus. • if you are allergic to pramipexole or to any of the other ingredients of this medicine (listed in section 6).

Mar 28, 2023 · Pramipexole is available as immediate-release tablets and as prolonged-release tablets. The immediate-release tablets can be taken by people with Parkinson's disease or people with restless leg syndrome. The prolonged-release tablets are suitable for people who have Parkinson's disease.

Jan 29, 2025 · Pipexus prolonged-release tablets are a once-a-day oral formulation of pramipexole. Initial treatment Doses should be increased gradually from a starting dose of 0.26 mg of base (0.375 mg of salt) per day and then increased every 5 - 7 days.

Jun 7, 2018 · bnf: 04090100; gtin: 5060078670067 If you find that some of the information provided is incorrect or you are looking for documents that are not available at this time, you can send a request to our Customer Service.

Pipexus is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson’s di­sease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the disease, through to late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dos...

Jan 7, 2025 · Pipexus is a nonergot-derivative dopamine receptor agonist which alleviates Parkinsonian motor deficits by directly stimulating postsynaptic dopamine activity on the striatum and substantia nigra It is used as an adjunct to levodopa for the symptomatic management of parkinsonian syndrome in patients with advanced disease.

Pipexus is used to treat the symptoms of primary Parkinson’s disease in adults. It can be used alone or in combination with levodopa (another medicine for Parkinson’s disease). 2.